Related Experiment Video
Updated: Jul 1, 2025

09:08
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
5.5K
[Paraneoplastic subacute cutaneous lupus erythematosus]
Margarida Amaral1,2, Alexander Michels3, Dagmar Jamiolkowski4,5
1Klinik für Dermatologie und Venerologie, Universitätsspital Basel, Petersgraben 4, 4031, Basel, Schweiz. margaridaflc@gmail.com.
Dermatologie (Heidelberg, Germany)
|March 5, 2024
Summary
Subacute cutaneous lupus erythematosus (SCLE) can be caused by cancer. A 70-year-old woman with SCLE was diagnosed with lung adenocarcinoma, highlighting the importance of considering paraneoplastic SCLE.
Area of Science:
- Dermatology
- Oncology
- Internal Medicine
Background:
- Subacute cutaneous lupus erythematosus (SCLE) has diverse causes, including idiopathic, drug-induced, and paraneoplastic origins.
- Paraneoplastic syndromes occur when cancer triggers a remote effect not directly related to tumor spread.
Observation:
- A case report details a 70-year-old female patient diagnosed with subacute cutaneous lupus erythematosus.
- The patient's SCLE was identified as paraneoplastic in origin.
- Further examination revealed an underlying lung adenocarcinoma in the patient.
Findings:
- The diagnosis of paraneoplastic SCLE was established in the context of an incidentally discovered lung adenocarcinoma.
- The patient presented with characteristic skin lesions in sun-unexposed areas and B symptoms, prompting further investigation.
Implications:
- This case underscores the necessity of considering paraneoplastic SCLE in the differential diagnosis of SCLE, particularly with specific clinical presentations.
- Early detection of underlying malignancies like lung adenocarcinoma can be facilitated by recognizing paraneoplastic SCLE.
- Awareness among clinicians is crucial for timely diagnosis and management of patients with paraneoplastic SCLE and associated cancers.
Keywords:
Adenocarcinoma of the lungsAutoimmune diseaseDermatosesHydroxychloroquineParaneoplastic syndromes
